Elizabeth Castaño

984 total citations
18 papers, 454 citations indexed

About

Elizabeth Castaño is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Elizabeth Castaño has authored 18 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 6 papers in Virology and 6 papers in Epidemiology. Recurrent topics in Elizabeth Castaño's work include HIV Research and Treatment (6 papers), Pneumonia and Respiratory Infections (4 papers) and HIV/AIDS drug development and treatment (4 papers). Elizabeth Castaño is often cited by papers focused on HIV Research and Treatment (6 papers), Pneumonia and Respiratory Infections (4 papers) and HIV/AIDS drug development and treatment (4 papers). Elizabeth Castaño collaborates with scholars based in Panama, United States and Colombia. Elizabeth Castaño's co-authors include Xavier Sáez‐Llorens, Octavio Ramilo, Donald M. Null, Jean J. Steichen, Edward M. Connor, Franklin H. Top, Pablo J. Sánchez, George H. McCracken, Ramiro García and E. Randall Lanier and has published in prestigious journals such as New England Journal of Medicine, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Elizabeth Castaño

15 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth Castaño Panama 9 187 170 119 77 70 18 454
Andrea Bedini Italy 14 221 1.2× 287 1.7× 40 0.3× 55 0.7× 85 1.2× 31 505
Venusto H. San Joaquin United States 11 139 0.7× 228 1.3× 90 0.8× 61 0.8× 35 0.5× 26 647
David Mushatt United States 13 260 1.4× 298 1.8× 117 1.0× 49 0.6× 28 0.4× 30 559
Shirley Delair United States 6 424 2.3× 82 0.5× 522 4.4× 77 1.0× 73 1.0× 15 841
Tak Lun Que China 12 209 1.1× 474 2.8× 113 0.9× 31 0.4× 44 0.6× 20 711
Urania Rappo United States 9 180 1.0× 246 1.4× 70 0.6× 89 1.2× 9 0.1× 19 451
F. Ajana France 10 178 1.0× 167 1.0× 43 0.4× 35 0.5× 54 0.8× 44 348
John F. Reinhardt United States 9 191 1.0× 265 1.6× 45 0.4× 101 1.3× 24 0.3× 15 388
Spyridon Karageorgos Greece 12 93 0.5× 154 0.9× 66 0.6× 51 0.7× 11 0.2× 30 427
John R. Ebright United States 12 307 1.6× 428 2.5× 176 1.5× 75 1.0× 25 0.4× 20 817

Countries citing papers authored by Elizabeth Castaño

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Castaño's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Castaño with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Castaño more than expected).

Fields of papers citing papers by Elizabeth Castaño

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Castaño. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Castaño. The network helps show where Elizabeth Castaño may publish in the future.

Co-authorship network of co-authors of Elizabeth Castaño

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Castaño. A scholar is included among the top collaborators of Elizabeth Castaño based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Castaño. Elizabeth Castaño is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Gaur, Aditya H., Jaime G. Deville, Pope Kosalaraksa, et al.. (2025). Longitudinal Evaluation of Bone Safety in Children and Adolescents With HIV-1 Starting Tenofovir Alafenamide-Containing Antiretroviral Therapy. Journal of the Pediatric Infectious Diseases Society. 14(7).
2.
Estripeaut, Dora, et al.. (2025). Point prevalence survey of antibiotics in a pediatric tertiary hospital in the Republic of Panama. Revista Panamericana de Salud Pública. 49. 1–1.
3.
Castaño, Elizabeth, et al.. (2023). Septicemia por Bacillus clausii posterior al uso de probióticos. Una complicación para tener presente. Andes pediatrica. 94(3). 379–385. 3 indexed citations
4.
Castaño, Elizabeth. (2022). De Otras Revistas: Toxicidad de medicamentos / Patologías Crónicas / COVID19. 91–93. 1 indexed citations
5.
Castaño, Elizabeth. (2021). Regreso a clases. 1–1.
6.
Sáez‐Llorens, Xavier, Elizabeth Castaño, Mobeen H. Rathore, et al.. (2014). A Randomized, Open-Label Study of the Safety and Efficacy of Switching Stavudine or Zidovudine to Tenofovir Disoproxil Fumarate in HIV-1–infected Children With Virologic Suppression. The Pediatric Infectious Disease Journal. 34(4). 376–382. 15 indexed citations
7.
Carrera, Jean‐Paul, Naomi L. Forrester, Eryu Wang, et al.. (2013). Eastern Equine Encephalitis in Latin America. New England Journal of Medicine. 369(8). 732–744. 77 indexed citations
8.
Estripeaut, Dora, Jonathan F Mosser, Meg Doherty, et al.. (2013). Mortality and Long-term Virologic Outcomes in Children and Infants Treated With Lopinavir/Ritonavir. The Pediatric Infectious Disease Journal. 32(12). e466–e472. 5 indexed citations
9.
Agudelo, Gloria María, et al.. (2012). [Incidence of nutritional support complications in critical patients: multicenter study].. PubMed. 26(3). 537–45. 3 indexed citations
10.
Agudelo, Gloria María, et al.. (2011). Incidencia de complicaciones del soporte nutricional en pacientes críticos: estudio multicéntrico. Nutrición Hospitalaria. 26(3). 537–545. 4 indexed citations
11.
McCoig, Cynthia, María Mercedes Castrejón, Jesús Saavedra‐Lozano, et al.. (2004). Cerebrospinal fluid and plasma concentrations of proinflammatory mediators in human immunodeficiency virus-infected children. The Pediatric Infectious Disease Journal. 23(2). 114–118. 31 indexed citations
12.
McCoig, Cynthia, María Mercedes Castrejón, Elizabeth Castaño, et al.. (2002). Effect of combination antiretroviral therapy on cerebrospinal fluid HIV RNA, HIV resistance, and clinical manifestations of encephalopathy. The Journal of Pediatrics. 141(1). 36–44. 43 indexed citations
13.
Sáez‐Llorens, Xavier, et al.. (2001). [Clinical and virological correlation between the cerebrospinal fluid and blood of HIV-infected children].. PubMed. 26. 13–8. 1 indexed citations
14.
Sáez‐Llorens, Xavier, et al.. (2000). Impact of an antibiotic restriction policy on hospital expenditures and bacterial susceptibilities: a lesson from a pediatric institution in a developing country. The Pediatric Infectious Disease Journal. 19(3). 200–206. 54 indexed citations
15.
Sáez‐Llorens, Xavier, et al.. (1998). [Importance of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired pneumonia].. PubMed. 23(2). 27–33. 8 indexed citations
16.
Sáez‐Llorens, Xavier, Elizabeth Castaño, Donald M. Null, et al.. (1998). Safety and pharmacokinetics of an intramuscular humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. The Pediatric Infectious Disease Journal. 17(9). 787–791. 102 indexed citations
17.
Sáez‐Llorens, Xavier, et al.. (1995). Prospective randomized comparison of cefepime and cefotaxime for treatment of bacterial meningitis in infants and children. Antimicrobial Agents and Chemotherapy. 39(4). 937–940. 93 indexed citations
18.
Sáez‐Llorens, Xavier, Elizabeth Castaño, Antonio Torres, et al.. (1995). Intrapartum Prophylaxis with Ceftriaxone Decreases Rates of Bacterial Colonization and Early-Onset Infection in Newborns. Clinical Infectious Diseases. 21(4). 876–880. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea Bedini Breakdown of academic impact, for papers by Venusto H. San Joaquin Breakdown of academic impact, for papers by David Mushatt Breakdown of academic impact, for papers by Shirley Delair Breakdown of academic impact, for papers by Tak Lun Que Breakdown of academic impact, for papers by Urania Rappo Breakdown of academic impact, for papers by F. Ajana Breakdown of academic impact, for papers by John F. Reinhardt Breakdown of academic impact, for papers by Spyridon Karageorgos Breakdown of academic impact, for papers by John R. Ebright
Rankless by CCL
2026